Cytokine Signalling Forum
Discussing RA: MACE in RA, data from the "JAK-pot" study, and combination therapy in MTX-IR RA
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:10:25
- Mas informaciones
Informações:
Sinopsis
Join Professor Iain McInnes for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where he discusses the latest updates in RA. In this episode, he discusses two papers: risk of MACE in patients with RA treated with JAKis compared to bDMARDs from the “JAK-pot” study, and the efficacy and safety of zimlovisertib, ritlecitinib and tofacitinib, alone and in combination, in patients with RA and an inadequate response to MTX.
